Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
V
082800
vs
K
KOSPI 200
Over the past 12 months, Vivozon Pharmaceutical Co Ltd has underperformed KOSPI 200, delivering a return of -53% compared to KOSPI 200's +125% growth.
Stocks Performance
082800 vs KOSPI 200
Performance Gap
082800 vs KOSPI 200
Performance By Year
082800 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Vivozon Pharmaceutical Co Ltd
Glance View
Vivozon Pharmaceutical is a South Korean drug company that develops, makes, and sells prescription medicines, with a strong focus on treatments used in hospitals such as anesthesia, pain control, and other central nervous system medicines. It supplies finished drugs to medical institutions and drug distributors, so its business is tied to how doctors and hospitals choose and use branded prescription products. The company makes money mainly by selling its own pharmaceutical products and, in some cases, by working with other drug makers on development or licensing deals. That means it is not just a factory or just a research shop; it sits in the middle of both drug development and commercialization. What makes its role different is that it concentrates on harder-to-develop hospital medicines rather than only high-volume everyday pills. That gives it a business based on specialized prescriptions, regulatory approvals, and long product lifecycles, where clinical trust and relationships with healthcare providers matter a lot.